• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氯丙嗪对Meth A细胞中DNA合成的抑制作用。

Inhibition of DNA synthesis in Meth A cells by chlorpromazine.

作者信息

Mizushima T, Natori S, Sekimizu K

机构信息

Faculty of Pharmaceutical Sciences, University of Tokyo, Japan.

出版信息

Biol Pharm Bull. 1993 Oct;16(10):953-5. doi: 10.1248/bpb.16.953.

DOI:10.1248/bpb.16.953
PMID:8287043
Abstract

We examined the influence of chlorpromazine, a phenothiazine derivative, on DNA synthesis in Meth A cells. Pulse-labelling experiments with [3H]thymidine showed that chlorpromazine inhibited DNA synthesis in cells cultured in vitro. The drug also inhibited DNA synthesis in isolated nuclei. Observation by fluorescence microscopy of fibroblastic cells stained with chlorpromazine indicated that the drug was localized in the cytoplasm and nuclear membranes, suggesting that it inhibited DNA synthesis in a manner dependent on the interaction of replication proteins with nuclear membranes. Meth A sarcomas growing in the endoderm of BALB/c mice regressed on intra-tumor injection of chlorpromazine, indicating that the drug has an anticancer action.

摘要

我们研究了吩噻嗪衍生物氯丙嗪对Meth A细胞DNA合成的影响。用[3H]胸腺嘧啶进行的脉冲标记实验表明,氯丙嗪在体外培养的细胞中抑制DNA合成。该药物也抑制分离细胞核中的DNA合成。用氯丙嗪染色的成纤维细胞的荧光显微镜观察表明,该药物定位于细胞质和核膜,这表明它以依赖于复制蛋白与核膜相互作用的方式抑制DNA合成。在BALB/c小鼠内胚层中生长的Meth A肉瘤在瘤内注射氯丙嗪后消退,表明该药物具有抗癌作用。

相似文献

1
Inhibition of DNA synthesis in Meth A cells by chlorpromazine.氯丙嗪对Meth A细胞中DNA合成的抑制作用。
Biol Pharm Bull. 1993 Oct;16(10):953-5. doi: 10.1248/bpb.16.953.
2
Inhibition of growth and of thymidine incorporation into DNA in Tetrahymena by chlorpromazine, pimozide and penfluridol.氯丙嗪、匹莫齐特和五氟利多对四膜虫生长及胸苷掺入DNA的抑制作用。
J Protozool. 1983 May;30(2):397-402. doi: 10.1111/j.1550-7408.1983.tb02938.x.
3
Inhibition of SV40 DNA replication in vitro by chlorpromazine.氯丙嗪对体外SV40 DNA复制的抑制作用。
Biol Pharm Bull. 1993 Jun;16(6):565-7. doi: 10.1248/bpb.16.565.
4
Effect of chlorpromazine on cell proliferation in the developing rat brain. A combined biochemical and morphological study.氯丙嗪对发育中大鼠脑内细胞增殖的影响。一项生化与形态学相结合的研究。
Brain Res. 1980 Dec 8;202(2):415-28. doi: 10.1016/0006-8993(80)90152-3.
5
Antineoplastic and cytogenetic effects of chlorpromazine on human lymphocytes in vitro and on Ehrlich ascites tumor cells in vivo.氯丙嗪对人淋巴细胞的体外抗肿瘤及细胞遗传学效应和对艾氏腹水瘤细胞的体内效应
Anticancer Drugs. 2009 Sep;20(8):746-51. doi: 10.1097/CAD.0b013e32832f567b.
6
Chlorpromazine: a potential anticancer agent?氯丙嗪:一种潜在的抗癌药物?
Biochem Biophys Res Commun. 1984 Nov 30;125(1):184-91. doi: 10.1016/s0006-291x(84)80352-6.
7
Inhibition of proliferation of lymphoma cells and T lymphocytes by suppressor cells from spleens of tumor-bearing mice.荷瘤小鼠脾脏抑制细胞对淋巴瘤细胞和T淋巴细胞增殖的抑制作用
J Immunol. 1975 Jan;114(1 Pt 1):206-10.
8
Concanavalin A induced apoptosis in fibroblasts: the role of cell surface carbohydrates in lectin mediated cytotoxicity.伴刀豆球蛋白A诱导成纤维细胞凋亡:细胞表面碳水化合物在凝集素介导的细胞毒性中的作用。
J Cell Physiol. 1995 Oct;165(1):119-33. doi: 10.1002/jcp.1041650115.
9
The effect of ring-substituted and quaternary chlorpromazine derivatives on the survival of the NK/Ly ascites tumor bearing mice.环取代及季铵化氯丙嗪衍生物对荷NK/Ly腹水瘤小鼠存活的影响。
Neoplasma. 1982;29(2):215-22.
10
Relationship between the displacement of phosphatidate phosphohydrolase from the membrane-associated compartment by chlorpromazine and the inhibition of the synthesis of triacylglycerol and phosphatidylcholine in rat hepatocytes.氯丙嗪使磷脂酸磷酸水解酶从膜相关区室移位与大鼠肝细胞中三酰甘油和磷脂酰胆碱合成受抑制之间的关系。
Biochim Biophys Acta. 1986 May 21;876(3):581-91. doi: 10.1016/0005-2760(86)90047-0.

引用本文的文献

1
Multifaceted effect of chlorpromazine in cancer: implications for cancer treatment.氯丙嗪在癌症中的多方面作用:对癌症治疗的启示。
Oncotarget. 2021 Jul 6;12(14):1406-1426. doi: 10.18632/oncotarget.28010.